Oppenheimer & CO Inc Rigel Pharmaceuticals Inc Transaction History

Oppenheimer & CO Inc

$6.42 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 08, 2022	SELL	$0.67 - $3.19 $7,134 - $33,967	-10,648 Reduced 20.0%	42,587 $48,000
Q1 2022 May 12, 2022	SELL	$2.22 - $3.45 $7,903 - $12,282	-3,560 Reduced 6.27%	53,235 $159,000
Q4 2021 Feb 02, 2022	SELL	$2.36 - $3.57 $10,841 - $16,400	-4,594 Reduced 7.48%	56,795 $151,000
Q3 2021 Nov 12, 2021	SELL	$3.5 - $4.5 $702,002 - $902,574	-200,572 Reduced 76.57%	61,389 $223,000
Q2 2021 Aug 03, 2021	BUY	$3.09 - $4.54 $611,022 - $897,748	197,742 Added 307.92%	261,961 $1.14 Million
Q1 2021 May 10, 2021	SELL	$3.35 - $4.93 $3,808 - $5,605	-1,137 Reduced 1.74%	64,219 $220,000
Q4 2020 Feb 11, 2021	SELL	$2.35 - $3.74 $258 - $411	-110 Reduced 0.17%	65,356 $229,000
Q3 2020 Nov 13, 2020	SELL	$1.78 - $4.13 $2,050 - $4,757	-1,152 Reduced 1.73%	65,466 $157,000
Q2 2020 Aug 11, 2020	BUY	$1.41 - $2.05 $1,410 - $2,050	1,000 Added 1.52%	66,618 $122,000
Q1 2020 May 08, 2020	SELL	$1.27 - $3.0 $895 - $2,115	-705 Reduced 1.06%	65,618 $102,000
Q4 2019 Feb 07, 2020	SELL	$1.6 - $2.43 $2,771 - $4,208	-1,732 Reduced 2.55%	66,323 $142,000
Q3 2019 Oct 31, 2019	SELL	$1.63 - $2.62 $7,571 - $12,169	-4,645 Reduced 6.39%	68,055 $127,000
Q2 2019 Aug 09, 2019	SELL	$2.02 - $2.61 $4,136 - $5,345	-2,048 Reduced 2.74%	72,700 $190,000
Q1 2019 Apr 24, 2019	SELL	$2.0 - $2.65 $4,606 - $6,102	-2,303 Reduced 2.99%	74,748 $192,000
Q3 2018 Oct 26, 2018	BUY	$2.6 - $3.59 $7,160 - $9,886	2,754 Added 3.71%	77,051 $247,000
Q2 2018 Aug 10, 2018	SELL	$2.83 - $4.11 $10,861 - $15,774	-3,838 Reduced 4.91%	74,297 $210,000
Q1 2018 May 01, 2018	SELL	$3.54 - $4.54 $7,345 - $9,420	-2,075 Reduced 2.59%	78,135 $277,000
Q4 2017 Feb 07, 2018	SELL	$3.23 - $4.3 $51 - $68	-16 Reduced 0.02%	80,210 $311,000
Q3 2017 Nov 09, 2017	BUY	$2.18 - $2.57 $174,892 - $206,180	80,226	80,226 $204,000

Others Institutions Holding RIGL

# of Institutions

Shares Held

334K

Call Options Held

Put Options Held

View Full List

About RIGEL PHARMACEUTICALS INC

Ticker RIGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 172,836,000
Market Cap $2.84B
Description
Rigel Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs to treat hematologic disorders, cancer, and rare immune diseases. The company offers Tavalisse, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia. It also develops Fostamatinib that is ...

More about RIGL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Oppenheimer & CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on Oppenheimer & CO Inc with notifications on news.

Account